Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1991 1
1994 1
1995 1
1998 2
2000 1
2001 2
2003 2
2004 6
2005 3
2006 3
2007 1
2008 1
2009 1
2011 2
2012 2
2013 3
2014 3
2015 3
2016 2
2017 1
2018 4
2019 2
2020 2
2021 2
2022 2
2023 1
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, Tewari KS, Salman P, Hoyos Usta E, Yañez E, Gümüş M, Olivera Hurtado de Mendoza M, Samouëlian V, Castonguay V, Arkhipov A, Toker S, Li K, Keefe SM, Monk BJ; KEYNOTE-826 Investigators. Colombo N, et al. N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18. N Engl J Med. 2021. PMID: 34534429 Clinical Trial.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Jun 20;42(18):2149-2160. doi: 10.1200/JCO.23.01500. Epub 2024 Mar 27. J Clin Oncol. 2024. PMID: 38537155 Free PMC article. Clinical Trial.
Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry.
Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, Fernández-Fernández E, Silva-Díaz M, Valero JA, González I, Sánchez Martín J, Narváez J, Calvo I, Mendizábal J, Abasolo Alcázar L, Loricera J, Ruíz-Román A, Moya P, Tortosa-Cabañas M, Estrada P, Prado-Galbarro FJ, Castañeda S, Blanco R; ARTESER Project Collaborative Group. Molina-Collada J, et al. Rheumatology (Oxford). 2025 Feb 1;64(2):697-703. doi: 10.1093/rheumatology/keae042. Rheumatology (Oxford). 2025. PMID: 38244610
Sustained drug-free remission in giant cell arteritis.
Narváez J, Domínguez M, Galíndez E, Mendizábal J, Abasolo L, Lluch J, Loricera J, Garrido N, Castañeda S, Moya P, Larena C, Estrada P, Galisteo C, Riveros Frutos A, Ortiz Sanjuán F, Salman T, Vasques Rocha M, Iñiguez CL, García González M, Blanco R; ARTESER Project Collaborative Group. Narváez J, et al. Rheumatology (Oxford). 2025 May 1;64(5):2919-2927. doi: 10.1093/rheumatology/keae644. Rheumatology (Oxford). 2025. PMID: 39589919
60 results